Search
This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. For Immediate Release February 7, 2017 Contact Consumers (718)366-2300 Kingsway Trading Inc. of Brooklyn, NY is recalling its 1.06 oz (30g)…
Read MoreProtect Access to Safe Prescription Medicines The United States Senate is currently considering proposals that could open our nation’s drug supply to unsafe and counterfeit drugs. Contact your legislators by selecting the appropriate letter below and tell them to oppose dangerous proposals like importation that endanger the U.S. drug supply and put patients’ lives at risk. Patients – Take Action!…
Read MoreDoctors Prosecuted for Buying Misbranded or Counterfeit Prescription Medicines, 2005—2016 Michael “Ted” Mimlitz, St. Louis, Missouri Pleaded guilty in January 2016 to charges related to distributing black market human growth hormone Sentenced to probation and to pay $89,500 in fines. Source: www.bizjournals.com/stlouis/blog/2016/04/doctor-gets-probation-for-giving-patients-mexican.html Gamal H. Eltabbakh, South Burlington, Vermont Agreed in February 2016 to pay $500,000 to settle a lawsuit related…
Read MoreArizona resident Betty Hunter died of lung cancer, but how much longer would she have lived if her oncologist had not treated her with counterfeit Avastin? A recent Danish documentary tells the tragic story of Arizona grandmother Betty Hunter, who in 2011 sought treatment for her lung cancer at an oncology clinic in Chandler Arizona. In the documentary, “Lethal Fake…
Read MoreAn investigation into the corruption of former Governor Javier Duarte has uncovered allegations that children with cancer were treated in state-run hospitals in Veracruz with counterfeit chemotherapy medicines due to budget shortfalls and lack of resources caused by his administration. The BBC reports, that when tested, the counterfeit chemotherapy drugs came back as an inert compound. Essentially, it was distilled…
Read MoreSince 2012, the FDA has issued warnings to more than 3,000 doctors, clinics and hospitals about eight different breaches in the U.S. drug supply chain by rogue distributors such as Richards Pharma, Canada Drugs, Medical Device King, Gallant Pharmaceuticals, and TC Medical. These rogue distributors offered 63 different non-FDA approved medicines. Have you or has someone you know taken medicine that these smugglers have sold?
Read MoreThe two men acted as U.S. distributors for a series of Thailand-based fake online pharmacy websites that sold imported and non-FDA approved medication to U.S. consumers. Troy Tapia and Anthony Rouse III of Louisiana have each been sentenced to three years probation after pleading guilty to fraud conspiracy, wire fraud, mail fraud and money laundering, the U.S. Department of Justice…
Read MoreTroy Tapia and Anthony Rouse III of Louisiana have each been sentenced to three years in prison for acting as drop-shippers for a Thailand-based fake online pharmacy operation. Each man pleaded guilty in federal court to charges of fraud conspiracy, wire fraud, mail fraud and money laundering. Rouse and Tapia fulfilled U.S. orders from Thai national Duangthip Chutivaraporn, the owner…
Read MoreIn 2016 alone, over 1,400 practitioners were warned by the FDA that their supplier was selling unapproved so-called “Botox.” With more than 2,400 professionals warned in the past 5 years, the expansion of use for this medication provides new markets for counterfeiters selling fake and misbranded drugs. Botulinum neurotoxin, or Botox as it is known, started as a treatment for…
Read MoreJanuary 5, 2017 Dear Senators and Representatives, In December of 2015 we released the attached letter warning Congress of the dangers to American patients from counterfeit drugs brought into America through “importation” proposals. As you consider the budget this year, we wanted to bring to your attention several recent tragic events that show the negative consequences of such policies: Counterfeit…
Read More